Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
GrowGeneration
GRWG
$105M
| $236K | ﹤0.01% |
+94,200
| New | +$231K |
|
|
KGEI
3077
Kolibri Global Energy
KGEI
$201M
| $236K | ﹤0.01% |
+61,250
| New | +$256K |
|
3078
Fidelity Total Bond ETF
FBND
$27.3B
| $235K | ﹤0.01% |
+5,100
| New | +$225K |
|
3079
SB Financial Group
SBFG
$170M
| $234K | ﹤0.01% |
+15,243
| New | +$210K |
|
3080
Solid Biosciences
SLDB
$967M
| $234K | ﹤0.01% |
38,071
+9,501
| +33% | +$30.4K |
|
3081
MVB Financial
MVBF
$400M
| $232K | ﹤0.01% |
10,300
+800
| +8% | +$16.9K |
|
3082
Neumora Therapeutics
NMRA
$298M
| $232K | ﹤0.01% |
+13,600
| New | +$167K |
|
|
AKYA
3083
DELISTED
Akoya BioSciences
AKYA
| $231K | ﹤0.01% |
47,400
-165,200
| -78% | -$686K |
|
3084
Cue Biopharma
CUE
$141M
| $230K | ﹤0.01% |
2,907
+914
| +46% | +$65.3K |
|
|
LYRA
3085
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $230K | ﹤0.01% |
878
-118
| -12% | -$21.4K |
|
3086
Invesco WilderHill Clean Energy ETF
PBW
$465M
| $229K | ﹤0.01% |
+7,700
| New | +$213K |
|
|
CUTR
3087
DELISTED
Cutera, Inc.
CUTR
| $228K | ﹤0.01% |
64,793
-96,405
| -60% | -$294K |
|
3088
Lifecore Biomedical
LFCR
$174M
| $227K | ﹤0.01% |
36,700
-32,600
| -47% | -$226K |
|
|
XOMA
3089
DELISTED
Xoma
XOMA
| $227K | ﹤0.01% |
12,296
-5,909
| -32% | -$97.3K |
|
3090
First Internet Bancorp
INBK
$253M
| $225K | ﹤0.01% |
9,319
-28,470
| -75% | -$550K |
|
|
TBHC
3091
DELISTED
The Brand House Collective
TBHC
| $225K | ﹤0.01% |
74,400
-21,800
| -23% | -$47.7K |
|
|
PET
3092
DELISTED
Wag!
PET
| $225K | ﹤0.01% |
128,186
+35,947
| +39% | +$63.6K |
|
|
BLTE
3093
Belite Bio
BLTE
$6.44B
| $224K | ﹤0.01% |
+4,900
| New | +$188K |
|
3094
Immix Biopharma
IMMX
$746M
| $224K | ﹤0.01% |
+32,400
| New | +$147K |
|
|
FPAY
3095
DELISTED
FlexShopper
FPAY
| $223K | ﹤0.01% |
133,607
-18,517
| -12% | -$23.9K |
|
3096
PEDEVCO
PED
$170M
| $223K | ﹤0.01% |
14,455
-3,600
| -20% | -$63.3K |
|
3097
Direxion Daily FTSE China Bear 3X ETF
YANG
$98.5M
| $223K | ﹤0.01% |
+870
| New | +$213K |
|
3098
BGSF Inc
BGSF
$59.9M
| $222K | ﹤0.01% |
23,600
+2,300
| +11% | +$21.8K |
|
3099
CervoMed
CRVO
$37.5M
| $222K | ﹤0.01% |
29,033
-200
| -0.7% | -$1.73K |
|
3100
Dare Bioscience
DARE
$22.2M
| $222K | ﹤0.01% |
59,950
+4,050
| +7% | +$18.5K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.